natural killer cell > 통합검색

통합검색

한빛사

내가 찾은 검색어

1natural killer cell

'natural killer cell' 에 대한 통합검색결과 195건입니다.

한빛사195건

최신순
관련도순

- 김혜리(고려대학교)
- 정아람(고려대학교)
Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery
- Adv. Sci. 07 March 2025 | https://doi.org/10.1002/advs.202412544
- 2025.03
- 바이오·의료융합
A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells
- J. Exp. Clin. Cancer Res. Mar 06 2025, 44 (1) | https://doi.org/10.1186/s13046-025-03351-5
- 2025.03
- 의약학
- 함형준(Mayo Clinic)
A novel dominant-negative variant of IRF8 in a mother and son: Clinical, phenotypic and biological characteristics
- J. Allergy Clin. Immunol. March 11, 2025 | https://doi.org/10.1016/j.jaci.2024.11.041
- 2025.03
- 생명과학
조서현

차의과학대학교 종양면역학연구실

NK 세포는 선천 면역의 핵심 요소로, 종양 세포를 인식·제거할 뿐만 아니라 다양한 면역 조절 인자를 분비하여 면역 환경을 조성하는 역할을 합니다. 현재 NK 세포 기반 치료는 크게 두 가지 방향으로 발전하고 있습니다. 첫째, CAR-NK 기술을 활용해 NK 세포의 표적성을 높이는 연구, 둘째, 병용 요법을 통해 NK 세포의 활성을 극대화하는 전략입니다. 하지만 NK 세포는 혈액암에서는 강력한 효과를 보이는 반면, 고형 종양에서는 충분히 침투하지 못하는 한계가 있습니다.
- J. Immunother. Cancer
- 2025.03.27
- 최승희(차의과학대학교)
- 박경순(차의과학대학교)
ELK3-CYFIP2 axis-mediated actin remodeling modulates metastasis and natural killer cell responses in triple-negative breast cancer
- J. Exp. Clin. Cancer Res. Feb 10 2025, 44 (1) | https://doi.org/10.1186/s13046-025-03309-7
- 2025.02
- 생명과학
Boosting tumor homing of endogenous natural killer cells via therapeutic secretomes of chemically primed natural killer cells
- J. Immunother. Cancer 14 February 2025;13:e010371 | https://doi.org/10.1136/jitc-2024-010371
- 2025.02
- 생명과학
Lenalidomide-utilizing self-assembled immunogenic cell death-inducing heparin/doxorubicin nanocomplex for anticancer immunotherapy
- Nano Today Available online 21 February 202 | https://doi.org/10.1016/j.nantod.2025.102677
- 2025.02
- 의약학
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
- J. Immunother. Cancer 16 February 2025 | https://doi.org/10.1136/ jitc-2024-010455
- 2025.02
- 의약학
Determinants of Response to Sequential Pembrolizumab with Trastuzumab Plus Platinum/5FU in HER2-positive Gastric Cancer: A Phase II Chemoimmunotherapy
- Clin. Cancer Res. February 17 2025 | https://doi.org/10.1158/1078-0432.CCR-24-3528
- 2025.02
- 의약학
Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkage
- Signal Transduct. Target. Ther. Jan 20 2025, 10 (1) | https://doi.org/10.1038/s41392-024-02106-6
- 2025.01
- 의약학
Single-cell RNA sequencing reveals transcriptional changes in circulating immune cells from patients with severe asthma induced by biologics
- Exp. Mol. Med. Dec 13 2024, | https://doi.org/10.1038/s12276-024-01368-y
- 2024.12
- 김원석(성균관대의대/삼성서울병원)
A Phase 2 study of acimtamig (AFM13) in patients with CD30-positive, relapsed or refractory peripheral T-cell lymphomas
- Clin. Cancer Res. November 12 2024 | https://doi.org/10.1158/1078-0432.CCR-24-1913
- 2024.11
Genome-wide transcriptome analysis of Aβ deposition on PET in a Korean cohort
- Alzheimers. Dement. 08 November 2024 | https://doi.org/10.1002/alz.14348
- 2024.11
- 생명과학
An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-β1-driven immune suppression
- Biomaterials Available online 10 October 2024, 122888 | https://doi.org/10.1016/j.biomaterials.2024.122888
- 2024.10
- 바이오·의료융합
- 윤준철(University of Missouri)
  Interview
- 이기호(University of Missouri)
Fetal bone engraftment reconstitutes the immune system in pigs with severe combined immunodeficiency
- Lab Anim. Sep 17 2024, | https://doi.org/10.1038/s41684-024-01439-7
- 2024.09
- 조용범(서울대학교)
- 도준상(서울대학교)
The extracellular matrix in solid tumor immunotherapy
- Trends Immunol. Aug 19 2024, S1471-4906(24)00184-4 | https://doi.org/10.1016/j.it.2024.07.009
- 2024.08
Use of a platform with lens-free shadow imaging technology to monitor natural killer cell activity
- Biosens. Bioelectron. Jun 19 2024, 261 S0956-5663(24)00517-7 | https://doi.org/10.1016/j.bios.2024.116512
- 2024.06
- 바이오·의료융합
CEACAM1-engineered MSCs have a broad spectrum of immunomodulatory functions and therapeutic potential via cell-to-cell interaction
- Biomaterials Jun 14 2024, 311 S0142-9612(24)00201-1 | https://doi.org/10.1016/j.biomaterials.2024.122667
- 2024.06
- 의약학
HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression
- Adv. Sci. 2024 Jun 3:e2400920 | https://doi.org/10.1002/advs.202400920
- 2024.06
- 의약학
- 임시영(University of Southern California)
- 정은지(University of Southern California)
Natural Killer Cell?Derived Extracellular Vesicles as Potential Anti?Viral Nanomaterials
- Adv. Healthc. Mater. Apr 27 2024, | https://doi.org/10.1002/adhm.202304186
- 2024.04